Patents by Inventor Siddhartha Jain

Siddhartha Jain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190246693
    Abstract: A vapor provision device including an atomizer for vaporizing a liquid; an air passage through the atomizer, the air passage exiting the device at a mouthpiece; at least one air inlet, joined by a channel to the air passage through the atomizer; and at least one resilient seal which acts to restrict air from the air inlet travelling to the air passage except through the channel.
    Type: Application
    Filed: March 21, 2017
    Publication date: August 15, 2019
    Inventors: MATTHEW JOEL NETTENSTROM, DAVID LEADLEY, STEVEN MICHAEL SCHENNUM, SIDDHARTHA JAIN
  • Publication number: 20190216129
    Abstract: A storage case for an electronic vapor provision device component having a reservoir for source liquid, the case defining an interior storage volume and including a receiving volume configured to receive at least one such component within the case; and at least one sealing means configured to inhibit liquid held in such a component received in the receiving volume from flowing into the interior storage volume.
    Type: Application
    Filed: July 17, 2017
    Publication date: July 18, 2019
    Inventors: Siddhartha JAIN, Rory FRASER, Steven Michael SCHENNUM, Thomas Michael MCKEON
  • Publication number: 20190150520
    Abstract: An aerosol delivery device including a mouthpiece end; an aerosol generation chamber in fluid communication with the mouthpiece end via a primary air channel, wherein the aerosol generation chamber comprises an aerosol source for generating an aerosol from a source material for inhalation by a user through the mouthpiece end during use; and a sensor for detecting when a user inhales on the mouthpiece end, wherein the sensor is in fluid communication with the mouthpiece end via a secondary air channel, and wherein the sensor is located further from the mouthpiece end than the aerosol source, and the secondary air channel bypasses the aerosol generation chamber.
    Type: Application
    Filed: May 19, 2017
    Publication date: May 23, 2019
    Inventors: Rory FRASER, Siddhartha JAIN
  • Publication number: 20190098931
    Abstract: An electronic vapor provision system includes a cartridge for storing material heatable to generate an aerosol and a control unit housing a battery to provide electrical power for heating, the cartridge and the control unit separably connectable together by at least one latching element, the latching element including a foot, and a leg joined at a first end to the foot by a flexible resilient joint and having a first latch member, the foot anchored within one of the cartridge and the control unit, and the other of the cartridge and the control unit having a second latch member on a surface, and positioned and configured to engage with the first latch member when the cartridge and the control unit are brought together with a substantially linear motion, and disengage with the first latch member when the cartridge and the control unit are pulled apart, the engagement and disengagement enabled by movement of the leg of the latching element about the flexible resilient joint.
    Type: Application
    Filed: March 21, 2017
    Publication date: April 4, 2019
    Applicant: NICOVENTURES HOLDINGS LIMITTED
    Inventors: DAVID LEADLEY, MATTHEW JOEL NETTENSTROM, SIDDHARTHA JAIN
  • Publication number: 20180280301
    Abstract: In one aspect, the present invention provides sterile microparticle compositions comprising biodegradable microparticles, which comprise at least one biodegradable polymer. In other aspects, the present invention provides methods of making and using such compositions as well as articles of manufacture and kits containing the same.
    Type: Application
    Filed: May 16, 2018
    Publication date: October 4, 2018
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
    Inventors: Derek O'Hagan, Manmohan Singh, Siddhartha Jain, Padma Malyala
  • Patent number: 10046048
    Abstract: The present invention generally relates to homogeneous suspensions of small molecule immune potentiators (SMIPs) that are capable of stimulating or modulating an immune response in a subject in need thereof. The homogeneous suspensions may be used in combinations with various antigens or adjuvants for vaccine therapies.
    Type: Grant
    Filed: July 5, 2016
    Date of Patent: August 14, 2018
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: David Skibinksi, Siddhartha Jain, Manmohan Singh, Derek O'Hagan
  • Publication number: 20180192700
    Abstract: An inductive heating assembly for generating an aerosol from an aerosol precursor material in an aerosol provision system, the inductive heating assembly including: a susceptor; and a drive coil arranged to induce current flow in the susceptor to heat the susceptor and vaporize aerosol precursor material in proximity with a surface of the susceptor, and wherein the susceptor includes regions of different susceptibility to induced current flow from the drive coil, such that when in use the surface of the susceptor in the regions of different susceptibility are heated to different temperatures by the current flow induced by the drive coil.
    Type: Application
    Filed: June 10, 2016
    Publication date: July 12, 2018
    Inventors: Rory FRASER, Colin DICKENS, Siddhartha JAIN
  • Publication number: 20180184712
    Abstract: An aerosol provision system for generating an aerosol from a source liquid, the aerosol provision system including: a reservoir of source liquid; a planar vaporizer comprising a planar heating element, wherein the vaporizer is configured to draw source liquid from the reservoir to the vicinity of a vaporizing surface of the vaporizer through capillary action; and an induction heater coil operable to induce current flow in the heating element to inductively heat the heating element and so vaporize a portion of the source liquid in the vicinity of the vaporizing surface of the vaporizer. In some example the vaporizer further comprises a porous wadding/wicking material, e.g. an electrically non-conducting fibrous material at least partially surrounding the planar heating element (susceptor) and in contact with source liquid from the reservoir to provide, or at least contribute to, the function of drawing source liquid from the reservoir to the vicinity of the vaporizing surface of the vaporizer.
    Type: Application
    Filed: June 10, 2016
    Publication date: July 5, 2018
    Inventors: Rory FRASER, Collin DICKENS, Siddhartha JAIN
  • Publication number: 20180168227
    Abstract: An electronic vapor provision system includes a control unit and a cartridge configured to engage with and disengage from one another substantially along a longitudinal axis. The cartridge includes a reservoir of liquid to be vaporized, and the control unit includes a battery and a tube portion disposed along said longitudinal axis. The system further includes an induction heating assembly comprising a drive coil and a heater element. The heater element is located in the cartridge for vaporizing the liquid. The cartridge is configured to feed liquid from the reservoir onto the heater element for vaporization. The drive coil is located in the tube portion of the control unit and disposed about the longitudinal axis. The cartridge is located at least partly within the tube portion when engaged with the control unit, such that the heater element is within the drive coil.
    Type: Application
    Filed: June 15, 2016
    Publication date: June 21, 2018
    Inventors: Rory FRASER, Colin DICKENS, Siddhartha JAIN
  • Patent number: 9950062
    Abstract: The invention provides a novel class of compounds, immunogenic compositions and pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with Toll-Like Receptors 7. In one aspect, the compounds are useful as adjuvants for enhancing the effectiveness of a vaccine.
    Type: Grant
    Filed: September 1, 2010
    Date of Patent: April 24, 2018
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Manmohan Singh, David Skibinski, Simona Cianetti, Francesco Doro, Siddhartha Jain
  • Patent number: 9795668
    Abstract: Particle compositions comprising adsorbed RNA replicons as well as methods of making and using the same are described.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: October 24, 2017
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Siddhartha Jain, Manmohan Singh, Derek O'Hagan
  • Publication number: 20160375132
    Abstract: The present invention generally relates to homogeneous suspensions of small molecule immune potentiators (SMIPs) that are capable of stimulating or modulating an immune response in a subject in need thereof. The homogeneous suspensions may be used in combinations with various antigens or adjuvants for vaccine therapies.
    Type: Application
    Filed: July 5, 2016
    Publication date: December 29, 2016
    Inventors: David Skibinski, Siddhartha Jain, Manmohan Singh, Derek O'Hagan
  • Patent number: 9517263
    Abstract: The invention provides, inter alia, immunogenic compositions that comprise (a) a first antigen, (b) polymeric particles and (c) a benzonaphthyridine compound, which compositions elicits an immune response when administered to a vertebrate subject. The invention also provides, inter alia, methods of producing immunogenic compositions and methods for using immunogenic compositions (e.g., for treatment), among other benefits.
    Type: Grant
    Filed: June 10, 2010
    Date of Patent: December 13, 2016
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Derek O'Hagan, Manmohan Singh, Siddhartha Jain, Sushma Kommareddy
  • Patent number: 9408907
    Abstract: The present invention generally relates to homogeneous suspensions of small molecule immune potentiators (SMIPs) that are capable of stimulating or modulating an immune response in a subject in need thereof. The homogeneous suspensions may be used in combinations with various antigens or adjuvants for vaccine therapies.
    Type: Grant
    Filed: December 15, 2010
    Date of Patent: August 9, 2016
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: David Skibinski, Siddhartha Jain, Manmohan Singh, Derek O'Hagan
  • Patent number: 9320748
    Abstract: The invention is in the field of salt forms of an immunopotentiator compound and their formulation for in vivo use. In particular the invention relates to arginine salts.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: April 26, 2016
    Assignee: Novartis AG
    Inventors: Stephanie Kay Dodd, Siddhartha Jain
  • Publication number: 20160074506
    Abstract: Particle compositions comprising adsorbed RNA replicons as well as methods of making and using the same are described.
    Type: Application
    Filed: November 23, 2015
    Publication date: March 17, 2016
    Inventors: Siddhartha Jain, Manmohan Singh, Derek O'Hagan
  • Patent number: 9192661
    Abstract: Particle compositions comprising adsorbed RNA replicons as well as methods of making and using the same are described.
    Type: Grant
    Filed: June 7, 2011
    Date of Patent: November 24, 2015
    Assignee: Novartis AG
    Inventors: Siddhartha Jain, Derek O'Hagan, Manmohan Singh
  • Publication number: 20150125475
    Abstract: The invention is in the field of salt forms of an immunopotentiator compound and their formulation for in vivo use. In particular the invention relates to arginine salts.
    Type: Application
    Filed: March 7, 2013
    Publication date: May 7, 2015
    Inventors: Stephanie Kay Dodd, Siddhartha Jain
  • Publication number: 20150030630
    Abstract: The efficacy of rabies vaccines can be enhanced by adjuvanting rabies virus immunogens with a mixture of a TLR agonist (preferably a TLR7 agonist) and an insoluble metal salt (preferably an aluminium salt). The TLR agonist is typically adsorbed to the metal salt. The rabies virus immunogen can also be adsorbed to the metal salt.
    Type: Application
    Filed: March 7, 2013
    Publication date: January 29, 2015
    Applicant: Novartis AG
    Inventors: Siddhartha Jain, Derek O'Hagan, Manmohan Singh
  • Patent number: 8689068
    Abstract: An integrated circuit (IC) having a low leakage current mode of operation has a number of modules for running respective applications. The modules have respective cells and respective test scan chain elements. The IC also has a controller for configuring an active module to operate in a functional mode and a selected inactive module to operate in a low leakage current mode. Configuring the selected inactive module to operate in low leakage current mode includes enabling scan mode of the selected inactive module, and applying a low leakage vector of input signals from the controller to the cells of the inactive module using the scan chain. Functional data outputs of the inactive module are disabled during low leakage current mode. In the meantime, the active modules continue to operate in the functional mode.
    Type: Grant
    Filed: November 28, 2011
    Date of Patent: April 1, 2014
    Assignee: Freescale Semiconductor, Inc.
    Inventors: Siddhartha Jain, Himanshu Goel, Himanshu Kukreja